ArticleBritish journal of cancer2015

A first-in-human phase I, dose-escalation, multicentre study of HSP990 administered orally in adult patients with advanced solid malignancies.

A Spreafico et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.